|
|
|
Volumn 40, Issue 2, 2007, Pages 82-100
|
|
Long-acting injectable risperidone in the treatment of schizophrenia in special patient populations.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NEUROLEPTIC AGENT;
RISPERIDONE;
ADULT;
AGE;
AGED;
CAUCASIAN;
DELAYED RELEASE FORMULATION;
ETHNOLOGY;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
NEGRO;
PATIENT COMPLIANCE;
PSYCHOLOGICAL ASPECT;
PSYCHOLOGICAL RATING SCALE;
PSYCHOLOGY;
PSYCHOSIS;
RECURRENT DISEASE;
REVIEW;
SCHIZOPHRENIA;
TREATMENT OUTCOME;
ADULT;
AFRICAN CONTINENTAL ANCESTRY GROUP;
AGE FACTORS;
AGED;
ANTIPSYCHOTIC AGENTS;
DELAYED-ACTION PREPARATIONS;
EUROPEAN CONTINENTAL ANCESTRY GROUP;
HUMANS;
INJECTIONS, INTRAMUSCULAR;
PATIENT COMPLIANCE;
PSYCHIATRIC STATUS RATING SCALES;
PSYCHOTIC DISORDERS;
RECURRENCE;
RISPERIDONE;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
TREATMENT OUTCOME;
|
|
EID: 34548574748
PISSN: 00485764
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (14)
|
|
References (52)
|
